Translational Regulation of Sf1 Integrates Alternative Splicing and Hematopoietic Stem Cell Fate
Listen to this summary
The authors investigate how mRNA isoform regulation influences the fate decisions of hematopoietic stem cells (HSCs) during their transition from quiescence to lineage commitment. They identify the splicing regulator Sf1 as a critical component of a translationally controlled splicing program that modulates HSC differentiation and DNA damage response through alternative splicing. This study highlights the intricate relationship between translational regulation, splicing, and HSC fate determination.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Blood
View all →Jun 25, 2026 · Blood
Combining Quizartinib with intensive chemotherapy in older patients with newly diagnosed AML: results of the UK NCRI AML18 Trial
Jun 25, 2026 · Blood
NG2-ITGA4 axis regulates Rho GTPases and leukemic aggressiveness in KMT2A-r B-ALL and is targetable with natalizumab
Jun 25, 2026 · Blood
Galectin-1 Fuels Monocyte Hyperinflammation and Represents a Novel Therapeutic Target in Myeloproliferative Neoplasms
Jun 24, 2026 · Blood
Direct and indirect regulation of fetal globin transcript by RNA-binding protein IGF2BP1
Jun 22, 2026 · Blood
Niche-targeted therapy via YAP/TAZ activation enhances hematopoietic regeneration
Jun 20, 2026 · Blood
Retinoic acid-driven expansion of CD16hiCD177+ neutrophils mediates steroid-resistant GI-GVHD
More in Internal Medicine
View all →Jun 25, 2026 · The American journal of sports medicine
Association of Central Acetabular Osteophytes With Microinstability and Increased Combined Anteversion in Borderline Dysplasia Hips
Jun 24, 2026 · Journal of hepatology
Regression of liver cirrhosis
Jun 24, 2026 · Journal of addiction medicine
Medicaid Prior Authorization and Discontinuation of Buprenorphine
Jun 24, 2026 · Journal of addiction medicine
Implementation of Dyadic Care to Support Clinical, Administrative, and Service Wraparound Needs for the Opioid-Exposed Mother and Infant
Jun 24, 2026 · Critical care medicine
Ethical Implications of the Slow Code: A Systematic Review of Ethics of Slow Codes in U.S. Hospitals
Jun 24, 2026 · Lancet (London, England)
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


